Why do patients with chagasic cardiomyopathy have worse outcomes than those with non-chagasic cardiomyopathy?;Por que os portadores de cardiomiopatia chagásica têm pior evolução que os não-chagásicos?

Arquivos Brasileiros de Cardiologia

Volumn 91, Issue 6, 2008, Pages

  Silva, Christiano Pereira ^a,b   Del Carlo, Carlo Henrique ^a   De Oliveira Jr , Mucio Tavares ^a   Scipioni, Airton ^a   Strunz Cassaro, Celia ^a   Ramirez, José Antonio Franchini ^a   Barretto, Antonio Carlos Pereira ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Chagas cardiomyopathy; Clinical evaluation; Heart failure, congestive

Indexed keywords

INTERLEUKIN 6; NORADRENALIN; SODIUM; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CHAGAS DISEASE; CONTROLLED STUDY; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HOSPITAL ADMISSION; HUMAN; HYPOBARISM; HYPOTENSION; INOTROPISM; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; SYSTOLIC BLOOD PRESSURE;

EID: 58849129806     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/S0066-782X2008001800006     Document Type: Article

References (13)

1. Yancy CW, Lopatin M, Stevenson LW, Marco T, Fonarow GC. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the acute decompensated heart failure national registry (ADHERE) Database. J Am Coll Cardiol. 2006; 47: 76-84.
2. Bestetti RB, Muccillo G. Clinical course of Chagas' heart disease: a comparison with dilated cardiomyopathy. Int J Cardiol. 1997; 60: 187-93.
3. Mady C, Cardoso RH, Barreto ACP, Da Luz PL, Bellotti G, Pileggi F. Survival and predictors of survival in patients with congestive heart failure due to Chagas' cardiomyopathy. Circulation. 1994; 90: 3098-102.
4. Freitas HF, Chizzola PR, Paes AT, Lima AC, Mansur AJ. Risk stratification in a Brazilian hospital-based cohort of 1220 outpatients with heart failure: role of Chagas' heart disease. Int J Cardiol. 2005; 102 (2): 239-47.
5. Rassi S, Barretto ACP, Porto CC, Pereira CR, Calaça BW, Rassi DC. Sobrevida e fatores prognósticos na insuficiência cardíaca sistólica com início recente dos sintomas. Arq Bras Cardiol. 2005; 4: 309-13.
6. Nunes MCP, Rocha MOC, Ribeiro ALP, Colosimo EA, Rezende RA, Carmo GA, et al. Right ventricular dysfunction is an independent predictor of survival in patients with dilated chronic Chagas' cardiomyopathy. Int J Cardiol. 2007, doi:10.1016/j.ijcard.2007.06.012.
7. Higuchi ML, de Morais CF, Pereira-Barreto AC, Lopes EA, Stolg N, Bellotti G, et al. The role of active myocarditis in the development of heart failure in chronic Chagas' disease: a study on endomyocardial biopsies. Clin Cardiol. 1987; 10: 665-70.
8. Lopes CBC. Influência de fatores socioeconômicos no prognóstico da insuficiência cardíaca. São Paulo: Ed USP; 2002.
9. Simões MV, Pintya AO, Bromberg-Marin G, Sarabanda AV, Antloga CM, Pazin-Filho A, et al. Relation of regional sympathetic denervation and myocardial perfusion disturbance to wall motion impairment in Chagas' cardiomyopathy. Am J Cardiol. 2000; 86: 975-81.
10. Martinelli M, De Siqueira SF, Moreira H, Fagundes A, Pedrosa A, Nishioka SD. Probability of occurrence of life-threatening ventricular arrhythmias in Chagas' disease versus non-Chagas' disease. Pacing Clin Electrophysiol. 2000; 23: 1944-6.
11. Rodriguez-Salas LA, Klein E, Acquatella H, Catalioti F, Dvalos VV, Gomez-Mancebo JR, et al. Echocardiographic and clinical predictors of mortality in chronic Chagas' disease. Echocardiography. 1998; 15: 271-8.
12. Rassi Jr A, Rassi A, Little WC, Xavier SS, Rassi SG, Rassi AG, et al. Development and validation of a risk score for predicting death in Chagas' heart disease. N Engl J Med. 2006; 355: 799-808.
13. Rassi Jr A, Rassi A, Rassi SG. Predictors of mortality in chronic chagas disease: a systematic review of observational studies. Circulation. 2007; 115: 1101-8.